Literature DB >> 1700825

Mechanism of antigenic variation in an individual epitope on influenza virus N9 neuraminidase.

G M Air1, W G Laver, R G Webster.   

Abstract

Monoclonal antibodies which inhibit influenza virus neuraminidase (NA) and which therefore indirectly neutralize virus infectivity bind to epitopes located on the rim of the active-site crater. The three-dimensional structure of one of these epitopes, recognized by monoclonal antibody NC41, has previously been determined (W. R. Tulip, J. N. Varghese, R. G. Webster, G. M. Air, W. G. Laver, and P. M. Colman, Cold Spring Harbor Symp. Quant. Biol. 54:257-263, 1989). Nineteen escape mutants of influenza virus A/tern/Australia/G70c/75 (N9) NA selected with NC41 were sequenced. A surprising restriction was seen in the sequence changes involved. Ten mutants had a Ser-to-Phe change at amino acid 372, and six others had mutations at position 367. No escape mutants with changes at 369 or 370 were found, although these mutations were selected with other antibodies and rendered the epitope unrecognizable by antibody NC41. Another N9 NA, from A/ruddy turnstone/NJ/85, which differs by 14 amino acids from the tern virus NA, still bound antibody NC41. Epitope mapping by selecting multiple escape mutants with antibody NC41 thus identified only three of the five polypeptide loops on NA that contact the antibody. Escape mutants selected sequentially with three different monoclonal antibodies showed three sequence changes in two loops of the NC41 epitope. The multiple mutants were indistinguishable from wild-type virus by using polyclonal rabbit antiserum in double immunodiffusion tests, but NA inhibition titers were fourfold lower. The results suggest that although the NC41 epitope contains 22 amino acids, only a few of these are so critical to the interaction with antibody that a single sequence change allows selection of an escape mutant. In that case, the variety of amino acid sequence changes which can lead to polyclonal selection of new epidemic viruses during antigenic drift might be very limited.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700825      PMCID: PMC248733     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Crystallization and preliminary X-ray analyses of two neuraminidases from influenza B virus strains B/Hong Kong/8/73 and B/Lee/40.

Authors:  P J Bossart; Y S Babu; W J Cook; G M Air; W G Laver
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

2.  Antigenic and genetic conservation of H3 influenza virus in wild ducks.

Authors:  H Kida; Y Kawaoka; C W Naeve; R G Webster
Journal:  Virology       Date:  1987-07       Impact factor: 3.616

3.  Crystal structures of neuraminidase-antibody complexes.

Authors:  W R Tulip; J N Varghese; R G Webster; G M Air; W G Laver; P M Colman
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1989

4.  Antigenic structure and variation in an influenza virus N9 neuraminidase.

Authors:  R G Webster; G M Air; D W Metzger; P M Colman; J N Varghese; A T Baker; W G Laver
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

5.  Structure of an escape mutant of glycoprotein N2 neuraminidase of influenza virus A/Tokyo/3/67 at 3 A.

Authors:  J N Varghese; R G Webster; W G Laver; P M Colman
Journal:  J Mol Biol       Date:  1988-03-05       Impact factor: 5.469

6.  Crystallization and preliminary X-ray analysis of type B influenza virus neuraminidase complexed with antibody Fab fragments.

Authors:  W G Laver; M Luo; P J Bossart; Y S Babu; C Smith; M A Accavitti; P A Tulloch; G M Air
Journal:  Virology       Date:  1988-12       Impact factor: 3.616

7.  Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid.

Authors:  W Weis; J H Brown; S Cusack; J C Paulson; J J Skehel; D C Wiley
Journal:  Nature       Date:  1988-06-02       Impact factor: 49.962

8.  Three-dimensional structure of neuraminidase of subtype N9 from an avian influenza virus.

Authors:  A T Baker; J N Varghese; W G Laver; G M Air; P M Colman
Journal:  Proteins       Date:  1987

9.  Location of antigenic sites on the three-dimensional structure of the influenza N2 virus neuraminidase.

Authors:  G M Air; M C Els; L E Brown; W G Laver; R G Webster
Journal:  Virology       Date:  1985-09       Impact factor: 3.616

10.  Protection against lethal influenza with neuraminidase.

Authors:  R G Webster; P A Reay; W G Laver
Journal:  Virology       Date:  1988-05       Impact factor: 3.616

View more
  19 in total

1.  Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).

Authors:  Upma Gulati; Chi-Ching Hwang; Lalitha Venkatramani; Shelly Gulati; Stephen J Stray; Janis T Lee; W Graeme Laver; Alexey Bochkarev; Adam Zlotnick; Gillian M Air
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Mutation signature in neuraminidase gene of avian influenza H9N2/G1 in Egypt.

Authors:  Zienab Mosaad; Abdelsatar Arafa; Hussein A Hussein; Mohamed A Shalaby
Journal:  Virusdisease       Date:  2017-05-23

3.  Correlation between antigenicity and variability in the vls antigenic variation system of Borrelia burgdorferi.

Authors:  Wei Zhou; Dustin Brisson
Journal:  Microbes Infect       Date:  2017-01-10       Impact factor: 2.700

4.  Generation of antiserum to specific epitopes.

Authors:  D C Marchion; D S Manning; W M Shafer; R C Judd
Journal:  Mol Biotechnol       Date:  1996-12       Impact factor: 2.695

5.  Conservation of type-specific B-cell epitopes of glycoprotein G in clinical herpes simplex virus type 2 isolates.

Authors:  J A Liljeqvist; B Svennerholm; T Bergström
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

6.  Comparative Efficacy of Monoclonal Antibodies That Bind to Different Epitopes of the 2009 Pandemic H1N1 Influenza Virus Neuraminidase.

Authors:  Lianlian Jiang; Giovanna Fantoni; Laura Couzens; Jin Gao; Ewan Plant; Zhiping Ye; Maryna C Eichelberger; Hongquan Wan
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

7.  Identifying antigenicity-associated sites in highly pathogenic H5N1 influenza virus hemagglutinin by using sparse learning.

Authors:  Zhipeng Cai; Mariette F Ducatez; Jialiang Yang; Tong Zhang; Li-Ping Long; Adrianus C Boon; Richard J Webby; Xiu-Feng Wan
Journal:  J Mol Biol       Date:  2012-05-17       Impact factor: 5.469

8.  Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites.

Authors:  M G Mateu; J Hernández; M A Martínez; D Feigelstock; S Lea; J J Pérez; E Giralt; D Stuart; E L Palma; E Domingo
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach.

Authors:  Rong Hai; Luis Martínez-Sobrido; Kathryn A Fraser; Juan Ayllon; Adolfo García-Sastre; Peter Palese
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

10.  Antigenicity of the N8 influenza A virus neuraminidase: existence of an epitope at the subunit interface of the neuraminidase.

Authors:  T Saito; G Taylor; W G Laver; Y Kawaoka; R G Webster
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.